Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
Nature Biotechnology
|
August 9, 2011
An unbiased genome-wide analysis of zinc-finger nuclease specificity
Richard Gabriel, Angelo Lombardo, Anne Arens, et al.
Blood
|
March 17, 2016
Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates
Christopher W Peterson, Jianbin Wang, Krystin K Norman, et al.
Nature Biotechnology
|
July 3, 2007
An improved zinc-finger nuclease architecture for highly specific genome editing
Jeffrey C Miller, Michael C Holmes, Jianbin Wang, et al.
Molecular Therapy. Methods & Clinical Development
|
August 11, 2020
AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate Reduction
Makiko Yasuda, Marshall W Huston, Silvere Pagant, et al.
Journal of Virology
|
March 8, 2019
Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1<sup>+</sup> and TIGIT<sup>+</sup> CD4 T Cells
George N Llewellyn, Eduardo Seclén, Stephen Wietgrefe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 24, 2019
Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
Anthony Conway, Matthew Mendel, Kenneth Kim, et al.
Blood
|
August 23, 2015
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
Rajiv Sharma, Xavier M Anguela, Yannick Doyon, et al.
Developmental Cell
|
March 18, 2009
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation
Gaetano Gargiulo, Samuel Levy, Gabriele Bucci, et al.
Molecular Therapy. Methods & Clinical Development
|
December 1, 2016
Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells
David L DiGiusto, Paula M Cannon, Michael C Holmes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 28, 2018
Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
Kanut Laoharawee, Russell C DeKelver, Kelly M Podetz-Pedersen, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
Nature Biotechnology
|
August 9, 2011
An unbiased genome-wide analysis of zinc-finger nuclease specificity
Richard Gabriel, Angelo Lombardo, Anne Arens, et al.
Blood
|
March 17, 2016
Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates
Christopher W Peterson, Jianbin Wang, Krystin K Norman, et al.
Nature Biotechnology
|
July 3, 2007
An improved zinc-finger nuclease architecture for highly specific genome editing
Jeffrey C Miller, Michael C Holmes, Jianbin Wang, et al.
Molecular Therapy. Methods & Clinical Development
|
August 11, 2020
AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate Reduction
Makiko Yasuda, Marshall W Huston, Silvere Pagant, et al.
Journal of Virology
|
March 8, 2019
Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1<sup>+</sup> and TIGIT<sup>+</sup> CD4 T Cells
George N Llewellyn, Eduardo Seclén, Stephen Wietgrefe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 24, 2019
Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
Anthony Conway, Matthew Mendel, Kenneth Kim, et al.
Blood
|
August 23, 2015
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
Rajiv Sharma, Xavier M Anguela, Yannick Doyon, et al.
Developmental Cell
|
March 18, 2009
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation
Gaetano Gargiulo, Samuel Levy, Gabriele Bucci, et al.
Molecular Therapy. Methods & Clinical Development
|
December 1, 2016
Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells
David L DiGiusto, Paula M Cannon, Michael C Holmes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 28, 2018
Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
Kanut Laoharawee, Russell C DeKelver, Kelly M Podetz-Pedersen, et al.
Page
of 9